Striking a cautiously optimistic note, a senior official in the Commerce Ministry and representatives of the Pharmaceuticals Export Promotion Council of India on Saturday said FY26 pharma exports are expected to remain in the positive zone notwithstanding the West Asia war’s impact on the March performance.

India's pharma exports exceed $28 billion, showing 5% growth, with projections for continued expansion despite currency fluctuations.